Coming off an unfavorable final rule for Medicare Advantage (MA) plans, Humana Inc. (NYSE: HUM) is still riding high. The company’s leaders explained the strategy behind recent succ… Read More

After the Centers for Medicare & Medicaid Services (CMS) released a final rule that poses sizable risk to its Medicare Advantage business, Humana Inc. (NYSE: HUM) leaders insisted panic… Read More

Humana Inc. (NYSE: HUM) has made substantial progress toward one of its major goals. That goal, of course, is scaling and maturing a risk-bearing value-based model that manages the provis… Read More

Humana Inc. (NYSE: HUM) has agreed to sell 60% of its hospice and personal care assets from Kindred at Home to the private equity firm Clayton Dubilier & Rice (CDR). The deal is expec… Read More